International Biotech Industry and Academic Leaders to Be Featured in BIO Translational Research Forum
WASHINGTON, D.C. (Thursday, June 16, 2011) - The 2011 Translational Research Forum, hosted by the Biotechnology Industry Organization (BIO), will explore the challenges and opportunities involved in translating innovative discoveries into usable products that can address some of the world’s most pressing concerns.. The forum will be held at 1-5pm on June 27th at the 2011 BIO International Convention in Washington, D.C. at the Walter E. Washington Convention Center.
With a keynote address by Dr. Frances S. Collins, MD, PhD, Director of the National Institutes of Health (NIH), the forum will explore topics such as how the private, public and academic sectors in three regions (the Americas, Europe and the Asia Pacific) can leverage meaningful partnerships, highlight emerging best practices, and explore risk-sharing at the clinical research stage and ways to bridge the gap in funding and know-how necessary to take university research to the next level.
The forum will feature the following speakers:
Mark Crowell, Executive Director, Innovation Partnerships, University of Virginia
Dr. Frances S. Collins, MD, PhD, Director, National Institutes of Health
Panel Discussion: Unique Funding Mechanisms and Ways to Generate Know-How (1:35 – 2:35 PM)
o Moderator: Barbara Handelin, PhD, President & Principal, BioPontis Alliance
o Dr. Michel Goldman, MD, PhD, Executive Director, Innovative Medicines Initiative
o Prof Dr P.R. Luijten, Chief Scientific Officer, Imaging Division and the Image Sciences Institute, University Medical Centre Utrecht
o Ora Dar, PhD, Head of Life Sciences Office of the Chief Science, Israeli Ministry of Industry Trade and Labor
Panel Discussion: Effective Strategies for Sustainably Positioning University Technologies (2:45 – 3:50 PM)
o Moderator: Jon Soderstorm, PhD, Managing Director, Office of Cooperative Research, Yale University
o Prof. Ian Frazer, Director, MB, ChB Edin., MD Melb, CEO & Research Director, Translational Research Institute
o Prof. Koen Debackere, PhD, Professor of Managerial Economics, Strategy and Innovation, Katholieke Universiteit Leuven
o Elias Caro, Vice President, Technology Development, Wallace H. Coulter Foundation
Panel Discussion: Risk Sharing and Clinical Research (3:50 – 4:55 PM)
o Moderator: Steve Usdin, Washington Editor, BioCentury, & Co-host, BioCentury This Week
o Dr. Roch Doliveux, Chief Executive Officer & Chairman of the Executive Committee, UCB
o Dr. Christopher Austin, MD, Therapeutics for Rare and Neglected Diseases Program, National Institutes of Health
o Aaron Schacht, Executive Director/COO Global External R&D, Lilly Research Laboratories
Closing Remarks (4:55 - 5:15 PM)
o Mark Crowell, Executive Director, Innovation Partnerships, University of Virginia
o Barbara Handelin, PhD, President & Principal, BioPontis Alliance
o Jon Soderstorm, PhD, Managing Director, Office of Cooperative Research, Yale University
o Steve Usdin, Washington Editor, BioCentury, & Co-host, BioCentury This Week
A reception will follow from 5:15-6:15pm.
The BIO International Convention is the largest global event for the biotechnology industry, offering networking and partnering opportunities with policymakers, scientists, CEOs and newsmakers, and hundreds of sessions covering biotech trends, policy issues and technological innovations. The Convention also features the BIO Business Forum, a unique platform for biotechnology and pharmaceutical companies, academic research institutions, and investors from around the world to gather and discuss strategic opportunities. For registration, conference agenda and exhibitor information, visit 2011 BIO International Convention.
Media registration is available online at http://convention.bio.org/media/.